Home › Companies › CABALETTA BIO INC. › 2024-2025
Compiled from SEC Form N-PX filings and CABALETTA BIO INC.’s Form 8-K, filed June 10, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 9, 2025: 6 items on CABALETTA BIO INC.’s Form 8-K, filed June 10, 2025: 2 approved · 4 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025
Explore CABALETTA BIO INC. in the interactive database Compare manager voting policies
These tallies are CABALETTA BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Steven Nichtberger, M.D. | 25,271,870 | -- | -- | 618,531 | 8,692,070 | 98% | Not verified | — |
| Elect Director: Mark Simon, MBA | 13,482,164 | -- | -- | 12,408,237 | 8,692,070 | 52.1% | Not verified | — |
| The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, recommended for ratification in Proposal 2 at the Annual M | 34,369,582 | 124,022 | 88,867 | -- | 0 | 99.6% | Not verified | — |
| The Company's stockholders approved the amendment to the Company's Third Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 300,000,000, recommended for approval | 32,584,702 | 1,962,883 | 34,886 | -- | 0 | 94% | Approved | — |
| The Company's stockholders approved, by non-binding advisory vote, the compensation of the Company's named executive officers in Proposal 4. | 13,973,541 | 11,809,869 | 106,991 | -- | 8,692,070 | 54.2% | Not verified | — |
| 6. Deemed not necessary because there was a quorum present and there were sufficient proxies at the time of the Annual Meeting to approve Proposal 3, it | 29,020,998 | 5,409,536 | 151,937 | -- | 0 | 84% | Approved | — |
Source: CABALETTA BIO INC., Form 8-K, filed with the SEC on June 10, 2025 — read the filing on EDGAR.
Each item below shows how the 104 asset managers that disclosed a CABALETTA BIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CABALETTA BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
52.1% Majority: yes · of votes cast
Description as filed by funds: To elect two class III directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Mark Simon, MBA
CABALETTA BIO INC.’s own tally for this item (“Elect Director: Mark Simon, MBA”): 13,482,164 for, 12,408,237 withheld, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 52.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 2,709,008 for, 4,333,195 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 1,930,685 | Withhold |
| Vanguard | 1,767,721 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 905,056 | Withhold |
| Prudential/PGIM | 902,204 | 0 | 0 | 0 | For |
| Fidelity | 0 | 0 | 0 | 409,339 | Withhold |
| Federated Hermes | 0 | 0 | 0 | 321,176 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 159,866 | Withhold |
| Equitable | 0 | 0 | 0 | 152,199 | Withhold |
| Thrivent | 0 | 0 | 0 | 92,880 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 64,117 | Withhold |
| TIAA | 0 | 0 | 0 | 39,686 | Withhold |
| Northern Trust | 0 | 0 | 0 | 36,626 | Withhold |
| Lincoln Financial | 34,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 31,471 | Withhold |
| Global X | 0 | 0 | 0 | 26,547 | Withhold |
| Pacific Life | 0 | 0 | 0 | 22,121 | Withhold |
| Nationwide | 0 | 0 | 0 | 21,929 | Withhold |
| John Hancock | 0 | 0 | 0 | 20,425 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 18,345 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 17,014 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 11,200 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 10,862 | Withhold |
| ProShares | 0 | 0 | 0 | 9,135 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 7,909 | Withhold |
| SEI | 0 | 0 | 0 | 7,500 | Withhold |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect two class III directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Steven Nichtberger, M.D.
CABALETTA BIO INC.’s own tally for this item (“Elect Director: Steven Nichtberger, M.D.”): 25,271,870 for, 618,531 withheld, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 7,036,617 for, 5,586 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,930,685 | 0 | 0 | 0 | For |
| Vanguard | 1,767,721 | 0 | 0 | 0 | For |
| BlackRock | 905,056 | 0 | 0 | 0 | For |
| Prudential/PGIM | 902,204 | 0 | 0 | 0 | For |
| Fidelity | 409,339 | 0 | 0 | 0 | For |
| Federated Hermes | 321,176 | 0 | 0 | 0 | For |
| Charles Schwab | 159,866 | 0 | 0 | 0 | For |
| Equitable | 152,199 | 0 | 0 | 0 | For |
| Thrivent | 92,880 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 64,117 | 0 | 0 | 0 | For |
| TIAA | 39,686 | 0 | 0 | 0 | For |
| Northern Trust | 36,626 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,471 | 0 | 0 | 0 | For |
| Global X | 26,547 | 0 | 0 | 0 | For |
| Pacific Life | 22,121 | 0 | 0 | 0 | For |
| Nationwide | 21,929 | 0 | 0 | 0 | For |
| John Hancock | 20,425 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 18,345 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,014 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 11,200 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 10,862 | 0 | 0 | 0 | For |
| ProShares | 9,135 | 0 | 0 | 0 | For |
| Goldman Sachs | 7,909 | 0 | 0 | 0 | For |
| SEI | 7,500 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
94% Approved · of votes cast
Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 150,000,000 TO 300,000,000.
CABALETTA BIO INC.’s own tally for this item (“The Company's stockholders approved the amendment to the Company's Third Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 300,000,000, reco”): 32,584,702 for, 1,962,883 against — passed, per its Form 8-K filed June 10, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the amendment to the Company's Third Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 300,000,000, recommended for approval”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 7,042,203 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,930,685 | 0 | 0 | 0 | For |
| Vanguard | 1,767,721 | 0 | 0 | 0 | For |
| BlackRock | 905,056 | 0 | 0 | 0 | For |
| Prudential/PGIM | 902,204 | 0 | 0 | 0 | For |
| Fidelity | 409,339 | 0 | 0 | 0 | For |
| Federated Hermes | 321,176 | 0 | 0 | 0 | For |
| Charles Schwab | 159,866 | 0 | 0 | 0 | For |
| Equitable | 152,199 | 0 | 0 | 0 | For |
| Thrivent | 92,880 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 64,117 | 0 | 0 | 0 | For |
| TIAA | 39,686 | 0 | 0 | 0 | For |
| Northern Trust | 36,626 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,471 | 0 | 0 | 0 | For |
| Global X | 26,547 | 0 | 0 | 0 | For |
| Pacific Life | 22,121 | 0 | 0 | 0 | For |
| Nationwide | 21,929 | 0 | 0 | 0 | For |
| John Hancock | 20,425 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 18,345 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,014 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 11,200 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 10,862 | 0 | 0 | 0 | For |
| ProShares | 9,135 | 0 | 0 | 0 | For |
| Goldman Sachs | 7,909 | 0 | 0 | 0 | For |
| SEI | 7,500 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
72% of fund votes cast · no official result
Description as filed by funds: TO APPROVE A PROPOSAL TO ADJOURN THE ANNUAL MEETING TO A LATER DATE OR DATES, IF NECESSARY OR APPROPRIATE, TO PERMIT FURTHER SOLICITATION AND VOTE OF PROXIES IN THE EVENT THAT THERE ARE INSUFFICIENT VOTES FOR, OR OTHERWISE IN CONNECTION WITH, THE APPROVAL OF PROPOSAL 3.
The 36 asset managers below reported 5,056,196 for, 1,986,007 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 1,930,685 | 0 | 0 | Against |
| Vanguard | 1,767,721 | 0 | 0 | 0 | For |
| BlackRock | 905,056 | 0 | 0 | 0 | For |
| Prudential/PGIM | 902,204 | 0 | 0 | 0 | For |
| Fidelity | 409,339 | 0 | 0 | 0 | For |
| Federated Hermes | 321,176 | 0 | 0 | 0 | For |
| Charles Schwab | 159,866 | 0 | 0 | 0 | For |
| Equitable | 145,799 | 6,400 | 0 | 0 | For |
| Thrivent | 92,880 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 64,117 | 0 | 0 | 0 | For |
| TIAA | 39,686 | 0 | 0 | 0 | For |
| Northern Trust | 36,626 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 34,200 | 0 | 0 | Against |
| AIG/SunAmerica | 31,471 | 0 | 0 | 0 | For |
| Global X | 26,547 | 0 | 0 | 0 | For |
| Pacific Life | 22,121 | 0 | 0 | 0 | For |
| Nationwide | 21,929 | 0 | 0 | 0 | For |
| John Hancock | 10,638 | 9,787 | 0 | 0 | Mixed |
| MASTER INVESTMENT PORTFOLIO | 18,345 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,014 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 11,200 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 10,862 | 0 | 0 | 0 | For |
| ProShares | 9,135 | 0 | 0 | 0 | For |
| Goldman Sachs | 7,909 | 0 | 0 | 0 | For |
| SEI | 7,500 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Combines 6 wordings of this item as funds reported it.
54.2% Majority: yes · of votes cast
Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
CABALETTA BIO INC.’s own tally for this item (“The Company's stockholders approved, by non-binding advisory vote, the compensation of the Company's named executive officers in Proposal 4.”): 13,973,541 for, 11,809,869 against, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 54.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 1,930,685 | 0 | 0 | Against |
| Vanguard | 0 | 1,767,721 | 0 | 0 | Against |
| BlackRock | 905,056 | 0 | 0 | 0 | For |
| Prudential/PGIM | 902,204 | 0 | 0 | 0 | For |
| Fidelity | 0 | 409,339 | 0 | 0 | Against |
| Federated Hermes | 321,176 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 159,866 | 0 | 0 | Against |
| Equitable | 81,169 | 71,030 | 0 | 0 | Mixed |
| Thrivent | 0 | 92,880 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 64,117 | 0 | 0 | 0 | For |
| TIAA | 0 | 39,686 | 0 | 0 | Against |
| Northern Trust | 36,626 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 31,471 | 0 | 0 | Against |
| Global X | 26,547 | 0 | 0 | 0 | For |
| Pacific Life | 22,121 | 0 | 0 | 0 | For |
| Nationwide | 21,929 | 0 | 0 | 0 | For |
| John Hancock | 0 | 20,425 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 18,345 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,014 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 0 | 11,200 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 10,862 | 0 | 0 | Against |
| ProShares | 0 | 9,135 | 0 | 0 | Against |
| Goldman Sachs | 0 | 7,909 | 0 | 0 | Against |
| SEI | 7,500 | 0 | 0 | 0 | For |
Fund voting reports, all 36 managers: 2,462,887 for, 4,579,316 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 39,770 | 3,995,808 | 0 | 0 | Against |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,742,237 | 1,742,237 | 0 | 0 | Mixed |
| Bain Capital Life Sciences Investors, LLC | 2,760,888 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 1,845,391 | 0 | 0 | 0 | For |
| BlackRock | 1,253,758 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 540,282 | 0 | 0 | Against |
| State Street | 450,096 | 3,454 | 0 | 0 | For |
| SUPERSTRING CAPITAL MANAGEMENT LP | 367,981 | 0 | 0 | 0 | For |
| Federated Hermes | 332,071 | 6,238 | 0 | 0 | For |
| Raiffeisen Bank International AG | 300,000 | 0 | 0 | 0 | For |
| AXA INVESTMENT MANAGERS UK Ltd | 0 | 270,271 | 0 | 0 | Against |
| Two Sigma | 0 | 267,636 | 0 | 0 | Against |
| Northern Trust | 219,551 | 1,387 | 0 | 0 | For |
| Charles Schwab | 0 | 159,866 | 0 | 0 | Against |
| Integral Health Asset Management, LLC | 153,245 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 115,655 | 0 | 0 | Against |
| Thrivent | 0 | 95,327 | 0 | 0 | Against |
| TCG Crossover Management, LLC | 86,795 | 0 | 0 | 0 | For |
| Vanguard | 0 | 69,241 | 0 | 0 | Against |
| AllianceBernstein | 0 | 65,052 | 0 | 0 | Against |
| FRED ALGER MANAGEMENT, LLC | 0 | 60,845 | 0 | 0 | Against |
| Nuveen | 0 | 51,867 | 0 | 0 | Against |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 42,578 | 0 | 0 | Against |
| Rhumbline | 0 | 12,077 | 0 | 0 | Against |
| Callan Family Office, LLC | 22,585 | 0 | 0 | 0 | For |
Institutional-manager reports, all 83 managers: 9,726,315 for, 7,630,745 against, 12,077 1 year. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
93% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: NON-BINDING, ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING, ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Thrivent | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 36 managers: 7,042,203 1 year. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| JENNISON ASSOCIATES LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| Raiffeisen Bank International AG | 0 | 0 | 0 | 0 | -- |
| AXA INVESTMENT MANAGERS UK Ltd | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Integral Health Asset Management, LLC | 153,245 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Thrivent | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| FRED ALGER MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 0 | 0 | 0 | -- |
| Rhumbline | 0 | 12,077 | 0 | 0 | Against |
| Callan Family Office, LLC | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Morton Capital Management LLC/CA | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 77 managers: 155,853 for, 12,352 against, 10,165,253 1 year, 300,000 2 year, 628 3 year. Showing the 25 largest; see all in the interactive database.
99.6% Majority: yes · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
CABALETTA BIO INC.’s own tally for this item (“The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, recommended for ratification in Propos”): 34,369,582 for, 124,022 against, per its Form 8-K filed June 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 7,042,019 for, 184 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,930,685 | 0 | 0 | 0 | For |
| Vanguard | 1,767,721 | 0 | 0 | 0 | For |
| BlackRock | 905,056 | 0 | 0 | 0 | For |
| Prudential/PGIM | 902,204 | 0 | 0 | 0 | For |
| Fidelity | 409,339 | 0 | 0 | 0 | For |
| Federated Hermes | 321,176 | 0 | 0 | 0 | For |
| Charles Schwab | 159,866 | 0 | 0 | 0 | For |
| Equitable | 152,199 | 0 | 0 | 0 | For |
| Thrivent | 92,880 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 64,117 | 0 | 0 | 0 | For |
| TIAA | 39,686 | 0 | 0 | 0 | For |
| Northern Trust | 36,626 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,471 | 0 | 0 | 0 | For |
| Global X | 26,547 | 0 | 0 | 0 | For |
| Pacific Life | 22,121 | 0 | 0 | 0 | For |
| Nationwide | 21,929 | 0 | 0 | 0 | For |
| John Hancock | 20,425 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 18,345 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 17,014 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 11,200 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 10,862 | 0 | 0 | 0 | For |
| ProShares | 9,135 | 0 | 0 | 0 | For |
| Goldman Sachs | 7,909 | 0 | 0 | 0 | For |
| SEI | 7,500 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 50,743,101 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 3.80% |
| 2 | Vanguard | 3.48% |
| 3 | BlackRock | 1.78% |
| 4 | Prudential/PGIM | 1.78% |
| 5 | Fidelity | 0.81% |
| 6 | Federated Hermes | 0.63% |
| 7 | Charles Schwab | 0.32% |
| 8 | Equitable | 0.30% |
| 9 | Thrivent | 0.18% |
| 10 | QUANTITATIVE MASTER SERIES LLC | 0.13% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 7.95% |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.87% |
| 3 | Bain Capital Life Sciences Investors, LLC | 5.44% |
| 4 | JENNISON ASSOCIATES LLC | 3.64% |
| 5 | BlackRock | 2.47% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.06% |
| 7 | State Street | 0.89% |
| 8 | SUPERSTRING CAPITAL MANAGEMENT LP | 0.73% |
| 9 | Federated Hermes | 0.67% |
| 10 | Raiffeisen Bank International AG | 0.59% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Jennison Associates LLC | 47.83% | 13G |
| PRUDENTIAL FINANCIAL INC | 47.83% | 13G |
| Cormorant Asset Management, LP | 20.69% | 13G |
| Bain Capital Life Sciences Opportunities III, LP | 19.07% | 13G |
| Millennium Management LLC | 10.11% | 13G |
| Citadel Advisors LLC | 9.24% | 13G |
| Alyeska Investment Group, L.P. | 8.87% | 13G |
| BlackRock | 6.80% | 13F |
| Kenneth Griffin | 6.21% | 13G |
| Nichtberger Steven | 5.98% | 13G |
Percentages above are of 50,743,101 shares outstanding, as reported by CABALETTA BIO INC. on its Form 10-Q dated May 9, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CABALETTA BIO INC.’s 10-Q dated May 9, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At CABALETTA BIO INC.'s shareholder meeting held June 9, 2025, in the 2024-2025 proxy season, 104 asset managers reported how they voted in their SEC Form N-PX filings, covering 993 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of our named executive officers. — FOR was 54.2% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CABALETTA BIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2025.
CABALETTA BIO INC. proxy season coverage: 2024-2025 (this page).
Download data (CSV): ballot items · votes by manager · column guide.